NCT07646418 Combined Effects of LIRT-BFR Therapy in Post- Stroke Patients
| NCT ID | NCT07646418 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2025-06-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stroke is a focal neurological deficit of sudden onset, with symptoms lasting more than 24 hours leading to consequences like impacting physical abilities, cognitive functions and emotional well-being, speech and language difficulties. Among various rehabilitation program, Blood flow restriction (BFR) therapy with low intensity resistance training has shown its promising results. Blood flow restriction training, also called Kaatsu, originated in Japan. So this study aims to determine the combined effects of Low Intensity Resistance Training with Blood Flow Restriction Therapy on Upper Limb Strength, Forward Reach and Sensorimotor function in Post-Stroke Patients.
Eligibility Criteria
Inclusion Criteria: * • 50 to 70 year of age (5) * Both males and females (5) * Generalized stroke population (both ischemic and hemorrhagic stroke) (9). * Post stroke patient after 1 month (5) * Barthel index scores ≥ 20 (10) * Spasticity level according to Modified Ashworth scale should be 1/+1 grade in the affected upper limb(7) * Muscle strength at grade 3 according to MMT of affected upper limb (7) Exclusion Criteria: * • People with a history of mental/cognitive illness (9) * History of transient ischemic attack (TIA) or recurrent stroke (8) * Diabetes with peripheral neuropathy (5) * Having resting blood pressure above 160/100 mmHg even after taking medications * Cardiovascular comorbidity (heart failure, unstable angina, aortic stenosis)
Contact & Investigator
Aiza Yousaf, MS-OMPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07646418 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 70 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07646418 currently recruiting?
Yes, NCT07646418 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07646418 trial being conducted?
This trial is being conducted at Sialkot, Pakistan.
Who is sponsoring the NCT07646418 clinical trial?
NCT07646418 is sponsored by Riphah International University. The principal investigator is Aiza Yousaf, MS-OMPT at Riphah International University. The trial plans to enroll 64 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.